September is National Sickle Cell Awareness Month. Sickle cell disease is an inherited disease that distorts soft and round red blood cells and turns them into hard, crescent shaped cells. These distorted red blood cells can cause those affected to experience extreme pain and often requires numerous blood transfusions to increase the number of normal red blood cells in the body and unblock blood vessels. According to the American Red Cross, a patient with sickle cell disease may need up to 100 units of blood each year to treat complications from the disease.
BioMedomics would like to reaffirm our commitment to improving the quality of life and health outcomes of those affected by sickle cell disease. We encourage everyone to be part of this international effort to increase awareness about sickle cell disease and sickle cell trait. Individuals and organizations can join our efforts by donating blood, engaging elected officials for proclamations, and distributing educational information to dispel the myths about sickle cell disease.
BioMedomics™ Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobin A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples.
- No electricity or instrumentation required
- Combined sensitivity and specificity of >99%
- Results in 5 minutes
- Suitable for newborn screening
- Ships worldwide
For more information, please email firstname.lastname@example.org. To place an order, please email email@example.com.